National Advisory Committee on Immunization (NACI): Membership and representation

Office of the Chief Medical Officer of Health
Halifax, Nova Scotia

Dr. Shelley Deeks is the Deputy Chief Medical Officer of Health at the Nova Scotia Office of the Chief Medical Officer of Health. She has a long-standing interest and passion for communicable disease control and immunization in general, and vaccine safety in particular, with over 120 peer-reviewed publications. Aside from her membership in the National Advisory Committee on Immunization, she is a past Chair of the World Health Organization's (WHO's) Immunization Practices Advisory Committee. Dr. Deeks holds Fellowships in Public Health in both Canada and Australia and completed the Canadian Field Epidemiology Program. She has over 20 years' experience as a public health physician and has worked at all levels of the public health system in Canada, and at the national level in Australia.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Alberta Health Services
Grey Nuns and University of Alberta Hospitals

Dr. Robyn Harrison is an Infectious Disease Specialist who works in Edmonton, Alberta. She is a Communicable Disease Consultant for the province wide Alberta Health Services Workplace Health and Safety Program (a position she has held since 2009). She has also served as consultant for the Covenant Health Alberta Occupational Health and Safety Program (2008-2014). Dr. Harrison is keenly interested in policy development and support for clinicians to prevent infection transmission in healthcare settings. She is a member of the Alberta Advisory Committee on Immunization, and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza H1N1 in 2009, and avian influenza is 2014. At a national level, she is working with the Public Health Agency of Canada as a member of the Prevention and Control of Occupational Infections in Health Care Settings Guideline Working Group to update and disseminate national evidence-based infection prevention and control (IPC) guidance.

Dr. Harrison obtained her medical degree at Dalhousie University, Nova Scotia; and she completed her Internal Medicine and Infectious Diseases subspecialty training at the University of Alberta. Most recently she completed an MSc in the combined areas of Public Health and Epidemiology through the London School of Hygiene and Tropical Medicine, England.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid or voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Dalhousie University
Halifax, Nova Scotia

Melissa K. Andrew is Professor of Geriatric Medicine at Dalhousie University in Nova Scotia, Canada. She did a Masters of Public Health at the London School of Hygiene and Tropical Medicine and completed her Interdisciplinary PhD at Dalhousie University on frailty and social vulnerability in older adults. She is an Associate Member of the Canadian Centre for Vaccinology and co-Principal Investigator of the Canadian Immunization Research Network Serious Outcomes Surveillance (SOS) Network, studying how frailty impacts influenza and COVID-19 vaccine effectiveness and clinical outcomes, especially in older people. She has worked on including frailty in vaccine clinical trials and serves on the Scientific and Executive Committees of the Global Influenza Hospital Surveillance Network.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?
Examples:

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to Vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

University of British Columbia
Vancouver, British Columbia

Dr. Julie Bettinger is an Associate Professor at the Vaccine Evaluation Center in the Department of Pediatrics at the University of British Columbia. She is an infectious disease epidemiologist whose research interests include vaccine safety and vaccine preventable diseases (specifically meningococcal and pneumococcal invasive infections), as well as attitudes and beliefs around immunization uptake and use. She is the data center director for the Canadian Immunization Monitoring Program, Active (IMPACT), an active surveillance network for vaccine preventable diseases and vaccine adverse events in 12 tertiary care pediatric hospitals across Canada and the principal investigator for CIRN's Canadian National Vaccine Safety (CANVAS) network, which monitors the safety of influenza vaccines each year.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Québec, QC

Dr. Brousseau conducts research on vaccine-preventable diseases. His areas of expertise are vaccination against pertussis, tetanus, pneumococcus, influenza and COVID-19 (immunogenicity, efficacy and impact of vaccination). He also conducts work on the optimization of vaccination services in Quebec. In 2020, he established a study on the seroprevalence of antibodies against the COVID-19 virus in health care workers in 10 hospital centers in Quebec.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Research Centre of the Sainte-Justine University Hospital

Montreal, Quebec

Hélène Decaluwe is Associate Professor in the Immunology and Rheumatology Division of the CHU Sainte-Justine (Department of Pediatrics, University of Montreal) since 2010 and Clinician Scientist and outgoing Deputy Head of the Immune Diseases and Cancer Research Axis at the CHU Sainte-Justine Research Center. Dr. Decaluwe graduated from the Faculty of Medicine at McGill University and completed her residency in pediatrics at the CHU Sainte-Justine (University of Montreal). She then completed her training in pediatric clinical immunology at the Necker Enfants-Malades Hospital (Paris, France) with Professor Alain Fischer. Her research training includes a Master and a PhD degree in immunology at Pierre and Marie Curie University (Paris 6) carried out in the laboratories of Professor Jean-Laurent Casanova and Professor James Di Santo respectively. Clinical researcher supported by the Fonds de Recherche du Québec en Santé (FRQS), she has dedicated her career to resolving the mechanisms of T cell differentiation in health, infection and primary immune deficiencies. The primary focus of her research is to better understand the role of cytokines in the differentiation of T cells in health and disease, and to develop novel immunotherapeutic approaches that target cytokine-dependent pathways and inhibitory receptors expressed on T cells, to cure chronic viral infections and cancer. Supported by both national (Canadian Institutes of Health Research, National Institute of Health) and private (Canadian Cancer Society/Cole Foundation, Charles Bruneau Foundation, Leukemia and Lymphoma Society of Canada) funding agencies, her laboratory has established a solid expertise in the field of T cell exhaustion, a differentiation pathway that limits optimal T effector cell functions and precludes memory T cell development. She is particularly involved in identifying the cytokine-dependent signaling pathways and transcription factors regulating T cell exhaustion during disease. She further aims to develop novel combined immunotherapeutic approaches that target inhibitory receptors and/or cytokine-dependent signaling pathways, to improve cure rates in cancer refractory patients and patients with primary immunodeficiencies. Hélène Decaluwe in also in recognized expert in the immune reconstitution of severe combined immunodeficiency patients treated by stem cell transplantation and aims to inform on the best therapeutic approaches to transplant these patients. Since the beginning of the current COVID-19 pandemic, her laboratory has been investigating T-cell immune correlates of protection to SARS-Cov-2, induced by natural infection and vaccination, through research initiatives supported by the Canadian Institutes of Health Research and the COVID-19 Immunity Task Force.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership ^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property ^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality ^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above ^{Footnote *}

Département de médicine sociale et préventive
Québec, Quebec

Philippe De Wals is Professor at the Department of Social and Preventive Medicine, Laval University, in Québec City, Canada. Professor De Wals gained his Medical Degree and a Doctorate in Public Health in his home country of Belgium, at the Louvain Catholic University. His early academic and professional career combined epidemiology research studies at the School of Public Health at the Louvain Catholic University with the practice of general medicine. Between 1980 and 2000 he worked as an epidemiologist for EUROCAT, a European network of population-based registries for the epidemiologic surveillance of congenital anomalies. In 1990, he moved to Canada and became the Head of the Department of Community Health Sciences at the University of Sherbrooke. In 1997, he was appointed visiting Professor at the School of Public Health at the University of North Carolina in Chapel Hill, USA.

Professor De Wals' research is centered on the epidemiology of infectious diseases, reproductive abnormalities, and the assessment of health services and public health programs and policies. He is the author of over 150 published articles in scientific journals and has contributed several chapters to textbooks. Currently, Professor De Wals is a member of the research centers at Quebec University Hospital and the Sherbrooke University Hospital and is a medical advisor to the Quebec National Institute of Public Health. In 2011, he was appointed as Scientific Director of the Evaluation Platform on Obesity Prevention at the Quebec Cardiology and Pneumology Institute.

In 1990, Professor De Wals was awarded the Jean Van Beneden Prize in recognition of his excellent work in the public health field, and in 2005, he was elected to the Royal Academy of Medicine of Belgium.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Québec, Quebec

Dr. Eve Dubé is a medical anthropologist. She is affiliated with Quebec National Institute of Public Health and the Research Center of the CHU-Québec. She is also an invited professor in anthropology at Laval University. Her research focuses on social, cultural and ethical issues around infectious diseases prevention. Most of her research aims at understanding why people accept, refuse or hesitate to receive vaccines and why healthcare providers adhere or not to vaccination recommendation for themselves, their families and their patients. She is the lead investigator of the Social Sciences and Humanities Network of the Canadian Immunization Research Network. From 2013 to 2014, she was a member of the World Health Organization (WHO) working group on vaccine hesitancy and she is currently part of the WHO Global Advisory Committee on Vaccine Safety where she is mainly involved in vaccine risk communication.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Toronto Public Health

Dr. Vinita Dubey graduated from the University of Toronto's Public Health and Preventive Medicine Residency Program. She holds an Adjunct Professor appointment with the University of Toronto's Dalla Lana School of Public Health. Since 2006, she has been an Associate Medical Officer of Health for Toronto Public Health in Communicable Disease Control. Specializing with the Vaccine Preventable Disease program includes involvement in the school based vaccine program, immunization school assessment program which suspends students who are not up-to-date with required vaccines, adverse event following immunization investigations, and outbreak management including the 2017 mumps outbreak in Toronto which was the largest mumps outbreak the city has had in over 20 years. She also works as an emergency medicine physician in a small community hospital.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

University of British Columbia
Vancouver, British Columbia

Dr. Kyla Hildebrand is a Pediatric Clinical Immunology and Allergy specialist and Clinical Associate Professor in the Department of Pediatrics at the University of British Columbia (UBC). Her subspecialty training was completed at the Hospital for Sick Children and University of Toronto. She completed a Master of Community Health Sciences program from the Dalla Lana School of Public Health, University of Toronto. She is a Clinical Investigator at the BC Children's Hospital Research Institute and Director of the Pediatric Clinical Immunology and Allergy Residency Training Program at UBC.

Dr. Hildebrand's clinical work involves assessing and managing complex patients presenting with allergic and immunological disorders including children requiring hematopoietic stem cell transplantation. She has been engaged with the Special Immunization Clinic (SIC) Network at UBC since 2014. She is a collaborator at the UBC site in the Canadian Health Infant Longitudinal Development (CHILD) study, designed to advance knowledge about the genetic and environmental determinates of atopic disease to determine how early life exposures relate to health and disease outcomes.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Alberta Health Services
Edmonton, Alberta

Dr. Kristin Klein is public health and preventive medicine specialist based out of Edmonton, Alberta. She holds two positions with Alberta Health Services, serving as Associate Provincial Medical Officer of Health for Communicable Disease Control and as a local Medical Officer of Health for Northern Alberta. Her educational background includes a Bachelor of Science from the University of Calgary, a medical degree and fellowship training in Public Health and Preventive Medicine from the University of Alberta. Prior to her role with AHS, Dr. Klein served as the Deputy Medical Officer of Health for the Government of Alberta. She has contributed to several provincial and national committees including representing the Council of Chief Medical Officers of Health as liaison member to NACI. She also holds a clinical appointment with the Faculty of Medicine and Dentistry at the University of Alberta.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Department of Health and Community Services
St. John's, Newfoundland and Labrador

Miranda O'Driscoll is the Provincial Disease Control Registered Nurse Specialist with the Department of Health and Community Services, Government of Newfoundland and Labrador. In her 16-year nursing career, Miranda has worked in a variety of roles as a registered nurse, all with a public health focus. Miranda's experience includes program policy planning, development, coordinating and implementation of communicable disease control programs, immunization standards and practice as well as public health programming for families at both a regional and provincial level. Miranda is a member of several federal committees whose work focus on similar strategies. Miranda has also played a vital role in the provincial response to COVID-19. Miranda received certification in Community Health through the Canadian Nurses Association and is currently working on her Masters in Public Health through Memorial University.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

McGill University Health Centre
Montreal, Quebec

Dr. Jesse Papenburg is an Assistant Professor of Pediatrics and an Associate Member of the Department of Epidemiology, Biostatistics and Occupational Health at McGill University. He practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children's Hospital of the McGill University Health Centre.

Dr. Papenburg obtained his medical degree from McGill University and completed residency and subspecialty training at the Montreal Children's Hospital. He then completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and a MSc in epidemiology at McGill. As a clinician scientist, Dr. Papenburg's research is on the epidemiology of viral respiratory infections, with a focus on diagnostics to improve treatment and outcomes. He actively contributes to national and provincial guidelines on RSV immunoprophylaxis and influenza antiviral treatment.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario

Dr. Anne Pham-Huy completed her medical degree at the University of Ottawa in 2003 and her subspecialty training in pediatric infectious diseases at McGill University in 2008. She also pursued additional training in clinical immunology. Dr. Pham-Huy has been at the Children's Hospital of Eastern Ontario (CHEO) since 2009. She is the lead physician for the primary immunodeficiency clinic at CHEO. Her research interests include the diagnosis and management of primary immunodeficiencies, infections in the immunocompromised host and immunization in special populations. She is the program director for the pediatric infectious diseases training program. She is also the current chair for Immunize Canada, a not-for-profit coalition of organizations with a specific interest in promoting the understanding and use of vaccines.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership ^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property ^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work ^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose

6. Sponsored travel ^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality ^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations ^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Toronto General Hospital
Toronto, Ontario

Beate Sander, PhD, is a Scientist at Public Health Ontario (PHO), Assistant Professor at the University of Toronto, Adjunct Faculty at York University, and Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES).

Beate's research interests lie in the area of economic evaluation with a focus on infectious diseases. She is leading multidisciplinary teams evaluating Zika and West Nile virus mitigation strategies using data-driven simulation models, and is linking laboratory with population-based administrative data, enabling novel approaches to study the burden of infectious diseases.

Beate served on the board of the Society of Medical Decision Making (SMDM) and is an editorial board member of the "Medical Decision Making" journal. Beate provides scientific advice to decision-makers and advisory bodies and serves on scientific working groups and networks.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Public Health Ontario
Toronto, Ontario

Dr. Sarah Wilson is a public health physician/medical epidemiologist at Public Health Ontario PHO where she works closely with the Immunization and Vaccine-Preventable Diseases team within the Communicable Diseases and Emergency Preparedness Response Department. In this role, she provides support to the surveillance of vaccine-preventable diseases, immunization coverage, vaccine safety, outbreak management, and participates in applied research. Sarah's research interests include applied vaccine program evaluation and immunization coverage assessment using a range of data sources including both routine surveillance and administrative data. She is a Fellow of the Royal College of Physicians and Surgeons in Public Health and Preventive Medicine and a graduate of the Canadian Field Epidemiology Program. She is an Assistant Professor at the Dalla Lana School of Public Health at the University of Toronto and an Adjunct Scientist at ICES (formerly known as the Institute for Clinical Evaluative Sciences).

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

Please provide any additional comments, if applicable:

I am listing my affiliation with the University of Toronto Centre for Vaccine-Preventable Diseases here as I understand the Centre has recently received funding from vaccine manufacturers to support post-doctoral fellowships that would be funded through the Centre. I will not be involved in the administration of the funds and will not receive any of the funds. I am unsure of the specific dollar amount as a formal announcement is forthcoming.

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

I receive a salary as an employee of Public Health Ontario. My role at Public Health Ontario includes providing scientific and technical advice to the Ontario Ministry of Health in regards to the implementation and monitoring of immunization programs.

Disclosure of affiliations and interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work ^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

I have never received speaking fees for any presentations/lectures. I have received travel honorariums for conferences and lectures, but never any funds from a pharmaceutical company or related third party.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

Please provide any additional comments, if applicable:

I have received funds from WHO for travel to conferences and meetings, and travel honorariums from conferences directly, but never any funds from a pharmaceutical company or related third party.

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Disclosure of affiliations and interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organization which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above ^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

Please provide any additional comments, if applicable:

No personal financial benefit of participation. I am not the holder of these funds.

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

Please provide any additional comments, if applicable:

I do routinely give presentations in the CME category for a variety of audiences including family physicians and other immunization service providers.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?

Please provide any additional comments, if applicable:

I am a full-time employee of the University of British Columbia funded by the BC Centre for Disease Control in a grant tenure position. I am full faculty at UBC and a Professor. My full-time service role with BCCDC is as the Medical Director of the Communicable Diseases and Immunization Service and Medical Head for Immunization Programs and Vaccine Preventable Diseases. All of the activities listed above are in the context of these positions.

Disclosure of Affiliations and Interests from the last 3 years

1. Participation in research^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated (e.g., as a trial investigator) in research related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Research that will be (or is likely to be) a component of a guideline recommendation on a topic
2. Research related to a competing intervention that will be (or is likely to be) relevant to the guideline recommendations
3. Research related to a company that produces a specific intervention under consideration in the guideline, but not related to that specific intervention

2. Equity ownership^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned stock, stock options, or other ownership interests in a company that manufactures or promotes a health technology related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

3. Intellectual property^{Footnote *}

Does you, your spouse/partner, or your immediate family members own or have owned patents or copyrights, and/or received royalties from these rights related to a health technology relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

4. Paid and voluntary work^{Footnote *}

Have you, your spouse/partner, or your immediate family members participated in paid of voluntary work relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Employment in any capacity by the manufacturer of a health technology assessment under consideration
2. Membership on a board of directors for a manufacturer of a health technology under consideration

5. Scientific meetings/lectures and speaking fees^{Footnote *}

Have you, your spouse/partner, or your immediate family members delivered presentations or lectures in scientific meetings, which are relevant to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Presentation at a scientific meeting (open or closed) in relation to an intervention or health technology that could be part of clinical practice guideline recommendations
2. Receiving income from lectures or other forms of teaching related to the health technology that could be part of a clinical practice guideline
3. Funding from the company producing the intervention or health technology, a competitor, or from a third party on behalf of the company / competitor to speak at conference, scientific meeting or education facility for any purpose.

6. Sponsored travel^{Footnote *}

Have you, your spouse/partner, or your immediate family members received funding or sponsorship for travel that was related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Any domestic or international travel either personally or to family or friends, funded in part or whole by a pharmaceutical company (or other company producing a health technology of interest) or related third party

7. Hospitality^{Footnote *}

Have you, your spouse/partner, or your immediate family members received any hospitality or gifts from a third party as part of an activity related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Example

1. Hospitality or gifts provided by a pharmaceutical company (or other company producing a health technology of interest) as part of a publicity or awareness-raising campaign

8. Sponsorship or associations^{Footnote *}

Have you, your spouse/partner, or your immediate family members been associated with an organization related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Involvement (as a general member or as part of organization's management) in an organisation which receives direct funding or sponsorship from a pharmaceutical company (or other company producing a health technology of interest)
2. Involvement (as a general member or as part of organization's management) in a non-profit or advocacy organization that may have a vested interest in the guideline topic

9. Public statements about the guideline topic^{Footnote *}

Have you, your spouse/partner, or your immediate family members published any statements or opinions related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans?

Examples

1. Advocating for a change in policy in relation to an intervention that may be part of the guideline scope
2. Individual has made public statement advocating that a intervention or health technology under consideration should or should not be recommended

10. Other relevant disclosures related to the guideline topic that do not fit the categories above^{Footnote *}

Have you, your spouse/partner, or your immediate family members have any other interests related to vaccines used for the prevention of infection and disease and the use of certain prophylactic agents (e.g. immunoglobulins) for humans that do not fit in the categories above?